- Home
- DERM vs CCRD Comparison
DERM vs CCRD Comparison
Compare DERM & CCRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DERM
- CCRD
- Stock Information
- Founded
- DERM 2014
- CCRD 1973
- Country
- DERM United States
- CCRD United States
- Employees
- DERM N/A
- CCRD N/A
- Industry
- DERM Biotechnology: Pharmaceutical Preparations
- CCRD
- Sector
- DERM Health Care
- CCRD
- Exchange
- DERM Nasdaq
- CCRD Nasdaq
- Market Cap
- DERM 174.7M
- CCRD 157.9M
- IPO Year
- DERM 2021
- CCRD N/A
- Fundamental
- Price
- DERM $6.88
- CCRD $20.55
- Analyst Decision
- DERM Strong Buy
- CCRD Hold
- Analyst Count
- DERM 2
- CCRD 1
- Target Price
- DERM $10.00
- CCRD $21.00
- AVG Volume (30 Days)
- DERM 78.2K
- CCRD 16.4K
- Earning Date
- DERM 05-20-2025
- CCRD 05-08-2025
- Dividend Yield
- DERM N/A
- CCRD N/A
- EPS Growth
- DERM N/A
- CCRD 187.14
- EPS
- DERM N/A
- CCRD 0.86
- Revenue
- DERM $56,134,000.00
- CCRD $61,011,000.00
- Revenue This Year
- DERM $29.83
- CCRD $9.82
- Revenue Next Year
- DERM $54.88
- CCRD N/A
- P/E Ratio
- DERM N/A
- CCRD $23.22
- Revenue Growth
- DERM N/A
- CCRD 12.31
- 52 Week Low
- DERM $3.20
- CCRD $11.57
- 52 Week High
- DERM $7.84
- CCRD $24.97
- Technical
- Relative Strength Index (RSI)
- DERM 52.73
- CCRD 57.31
- Support Level
- DERM $6.47
- CCRD $16.84
- Resistance Level
- DERM $7.15
- CCRD $20.30
- Average True Range (ATR)
- DERM 0.49
- CCRD 1.19
- MACD
- DERM -0.09
- CCRD 0.08
- Stochastic Oscillator
- DERM 37.25
- CCRD 72.50
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
About CCRD CoreCard Corporation
CoreCard Corp is engaged in the business of providing technology solutions and processing services to the financial technology and services market. It designs, develops and markets a comprehensive suite of software solutions to program managers, accounts receivable businesses, financial institutions, retailers and processors to manage their credit and debit cards, prepaid cards, private label cards, fleet cards, buy now pay later programs, loyalty programs and accounts receivable and loan transactions. The CoreCard software platform and modules include CoreENGINE, CoreISSUE, CoreFRAUD, CoreCOLLECT, CoreAPP, CoreMONEY and CoreACQUIRE. Its customers are located in the U.S, European Union and the Middle East of which key revenue is derived from the U.S.